OnCore Login

Sponsor-Investigators

Muhammad Furqan

BTCRC-LUN18-363

A Phase II Study of Chemo-Immunotherapy Followed by Durvalumab (MEDI4736) and Ceralasertib (AZD6738) in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Big Ten Cancer Research Consortium BTCRC-LUN18-363
Status
Open to Accrual
Cancer Types
Lung
Locations
Indiana University Melvin and Bren Simon Comprehensive Cancer Center, The Ohio State University, University of Illinois Cancer Center, University of Iowa Holden Comprehensive Cancer Center, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
Read more
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278